GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

FHS
June 21, 2024
3:08 am

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.

HitGen and SGC enter drug discovery partnership

HitGen’s OpenDEL platform can be used for running affinity screening experiments against protein targets. Credit: Gorodenkoff/Shutterstock.com. Chinese company HitGen and the Structural Genomics Consortium (SGC)

September 29, 2023

Experts Await Serology Results From H5N1 Patient’s Close Contacts

In the absence of PCR testing, infectious disease experts and epidemiologists are anxiously awaiting serology results from the household contact and two healthcare workers who

September 26, 2024

Silver Tsunami: Rise of Tech-Enabled Senior Home Care

Aaron Marcum, founder of Breakaway Home Care Accelerator With the advancements in medical care and the resilience of the human spirit, most people now live

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.